Skip to content

Clinical trials

Phase 1/2 Colorectal Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 1/2 Country / region: Taiwan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20141
20171
20192
20201
20212
20221
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Active, not recruiting3
Terminated2
Unknown status2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alentis Therapeutics AG1
Anbogen Therapeutics, Inc.1
Daiichi Sankyo1
Eisai Inc.1
Genmab1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Merck Sharp & Dohme LLC1
NGM Biopharmaceuticals, Inc1
National Taiwan University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms13
Carcinoma, Non-Small-Cell Lung5
Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Carcinoma, Hepatocellular3
Melanoma3
Ovarian Neoplasms3
Biliary Tract Neoplasms2
Carcinoma2
Carcinoma, Neuroendocrine2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.